WANBURYNSEWANBURY LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 11 Aug, 2026 · 20:47 IST

Wanbury Q1 results, ESOP allotment, re-appointment of Whole-time Director

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.3%Reaction day
₹256.50
prior close
₹243.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+1.9% vs market
Pharmaceuticals peers, median of 165sector-0.6%+2.9% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+8.4
10m
+1.4
15m
-1.0
30m
-3.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.3+0.4+1.9-0.6+2.9
Next day
-2.3+0.5-2.9-0.3-2.1
2d
+0.2+0.6-0.4-0.7+0.9
3d
-2.0+0.7-2.7-1.4-0.6
4d
-0.2+1.1-1.3-1.1+0.9
5d
+4.5+0.5+4.0-2.0+6.4
1w
+3.0+1.3+1.7-1.4+4.4
15d
-4.5+0.5-5.0-0.9-3.6
1m
-12.3-0.8-11.4-0.2-12.1
2m
-25.2-0.9-24.2-3.2-22.0
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Wanbury Limited board approved Q1 FY27 results with revenue of Rs.165.58 crore (vs Rs.163.18 crore YoY) but profit after tax fell sharply to Rs.3.24 crore from Rs.13.49 crore. Company allotted 27,530 equity shares under ESOP 2016 and re-appointed Mr. Mohan Kumar Rayana as Whole-time Director for 5 years from August 21, 2026. Borrowings of Rs.205 crore were raised from NBFCs to repay high-cost debt.

Likely market impact

Mixed Q1 with revenue flat but profits down sharply. Director re-appointment and ESOP allotment are routine. Promoter pledge release is positive.